Mukka Proteins Wins Customs Tribunal Case, ₹15.24 Crore Demand Set Aside
Mukka Proteins Limited has won a significant customs tribunal case. The Hon'ble CESTAT set aside a demand of ₹15,24,30,536, including interest and penalties, related to imported fish meal valuation. The order, dated June 24, 2026, was received on August 6, 2026. The company may also claim a refund of ₹75 lakh.
The outcome of this litigation is material as it involves a significant amount (₹15.24 crore) and potential refund, positively impacting the company's financial standing. However, it is not a fundamental change in business operations.
The company has won a significant litigation case, resulting in the setting aside of a substantial demand, which is a positive development.
Mukka Proteins Limited has received a Final Order from the Hon'ble Customs, Excise & Service Tax Appellate Tribunal (CESTAT), Bangalore Regional Bench, concerning customs appeals against an Order-in-Original dated April 30, 2024. The CESTAT, through its Final Order Nos. 20934–20937/2026 dated June 24, 2026, set aside the demand of ₹15,24,30,536, along with unquantified interest and penalties.
The litigation involved the valuation of imported fish meal between September 2014 and October 2015. The Customs Department had alleged undervaluation and misdeclaration, leading to a Show Cause Notice in December 2017. An earlier order from CESTAT in March 2022 had remanded the matter for fresh adjudication. The subsequent Order-in-Original from the Commissioner of Customs, Mangalore, dated April 30, 2024, confirmed the demands.
The CESTAT's latest order, received by the company on August 6, 2026, at 11:00 a.m., ruled that the Department failed to establish undervaluation with sufficient evidence, rendering the demand unsustainable. Consequently, the demand for customs duty, interest, redemption fine, and penalties was set aside. The company may also be eligible to claim a refund of ₹75,00,000 previously appropriated under the Order-in-Original.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.